CYTHライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	28 089.00
平均出来高	100 379
時価総額	36.18M
EPS	$0 ( 2024-03-18 )
次の収益日	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.020
ATR14	$0.0120 (0.95%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Sieger Markus	Buy	14 004	Common Stock
2024-02-13	Ostronic Francis Patrick	Buy	8 703	Common Stock
2024-02-13	Toig Randall M.	Buy	7 516	Common Stock
2024-02-13	Strattan Ce Rick	Buy	6 963	Common Stock
2024-02-13	Wong Vivien	Buy	6 330	Common Stock

INSIDER POWER
50.71
Last 99 transactions
Buy: 16 269 213 \| Sell: 5 479 045

ボリューム相関

長: 0.19 (neutral)

短: 0.15 (neutral)

Signal:(37.758) Neutral

Cyclo Therapeutics, Inc. 相関

10 最も正の相関
STRO	0.944
ASPU	0.94
LSXMK	0.922
LSXMA	0.922
PRTG	0.917
NAKD	0.917
BOCH	0.915
SIRI	0.911
ACRX	0.91
BFRI	0.91

10 最も負の相関
PAE	-0.928
RMRM	-0.927
APOP	-0.916
PESI	-0.907
EBSB	-0.905
INTA	-0.905
LMNR	-0.905
NCAC	-0.903
NVDA	-0.903
FTNT	-0.902

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Cyclo Therapeutics, Inc. 相関 - 通貨/商品

-0.33
( neutral )

-0.01
( neutral )

0.00
( neutral )

Cyclo Therapeutics, Inc. 財務諸表

Annual	2023
収益:	$1.08M
総利益:	$-2.41M (-223.91 %)
EPS:	$-1.230

FY	2023
収益:	$1.08M
総利益:	$-2.41M (-223.91 %)
EPS:	$-1.230

FY	2022
収益:	$1.38M
総利益:	$1.24M (89.90 %)
EPS:	$-1.810

FY	2021
収益:	$1.59M
総利益:	$1.43M (90.16 %)
EPS:	$-2.24

Financial Reports:

No articles found.

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.